OR51E2 and prostate carcinoma: OR51E2 is expressed in prostate epithelial cells, and expression is significantly increased in prostate intraepithelial neoplasia and prostate cancer relative to healthy tissue and benign prostatic hyperplasia (Weng et al. 2005).